Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2002);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;21191;Pharmacological Reviews;journal;15210081, 00316997;12.251;Q1;241;23;64;6417;1857;63;27.44;279;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
2;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.266;Q1;210;23;78;2986;1814;77;20.7;129.83;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
3;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;3.919;Q1;225;154;448;4295;3276;348;6.31;27.89;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
4;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.18;Q1;233;196;592;18002;3216;573;5.2;91.85;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
5;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.046;Q1;190;165;354;6092;2095;332;5.81;36.92;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
6;82448;Mutation Research - DNA Repair;journal;09218777;2.943;Q1;75;0;218;0;933;215;4.16;0;Netherlands;Western Europe;Elsevier BV;1989-2001;"Genetics (Q1); Molecular Biology (Q1); Toxicology (Q1)"
7;26371;Natural Product Reports;journal;02650568, 14604752;2.877;Q1;188;43;114;7090;641;113;5.92;164.88;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
8;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.773;Q1;202;339;982;12909;5921;980;5.73;38.08;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
9;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;2.731;Q1;211;66;203;9004;1433;200;6.13;136.42;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;2.628;Q1;66;6;44;2012;228;44;5.62;335.33;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
11;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.219;Q1;269;714;1926;19854;9421;1846;4.81;27.81;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;18148;Pain;journal;18726623, 03043959;2.192;Q1;269;258;760;10532;4136;707;5.11;40.82;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
13;12455;Molecular Therapy;journal;15250024, 15250016;2.173;Q1;185;227;384;7374;2171;323;5.65;32.48;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.161;Q1;227;203;511;9564;2499;477;4.6;47.11;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
15;19427;Advances in Pharmacology;journal;15578925, 10543589;2.06;Q1;78;0;46;0;159;37;2.97;0;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
16;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;2.023;Q1;183;147;263;15518;1517;241;4.98;105.56;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
17;20435;Neuropharmacology;journal;00283908, 18737064;1.892;Q1;176;248;694;10924;2868;694;3.55;44.05;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
18;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.881;-;144;99;274;3006;1595;269;6.06;30.36;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
19;19907;Medicinal Research Reviews;journal;01986325, 10981128;1.869;Q1;134;26;84;3534;481;83;6.92;135.92;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
20;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.732;Q1;89;4;31;616;156;30;5.21;154;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
21;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.709;Q1;276;609;1591;24619;7593;1508;4.66;40.43;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
22;26514;Tetrahedron Letters;journal;00404039, 18733581;1.681;Q1;173;2276;6878;54294;17048;6876;2.49;23.86;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
23;26512;Tetrahedron;journal;14645416, 00404020;1.673;Q1;226;1105;3368;43521;8478;3353;2.58;39.39;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
24;21782;Psychopharmacology;journal;00333158, 14322072;1.66;Q1;202;336;1030;15215;3845;1000;3.57;45.28;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
25;15984;Journal of Molecular Medicine;journal;09462716, 14321440;1.64;Q1;146;110;348;5204;1188;324;3.04;47.31;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
26;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.582;Q1;233;614;1945;23100;8328;1944;4.34;37.62;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
27;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;1.558;Q1;33;39;27;930;157;27;1.6;23.85;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Cancer Research (Q1); Oncology (Q1); Pharmacology (Q1)"
28;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.496;Q1;223;540;2033;21984;7244;2028;3.51;40.71;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
29;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.463;Q1;72;54;122;1786;368;122;2.94;33.07;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Immunology (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Microbiology (medical) (Q1); Pharmacology (Q1)"
30;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.453;Q1;94;72;166;2555;791;166;4.64;35.49;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
31;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.4;Q1;203;417;1174;8560;3751;910;3.13;20.53;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.385;Q1;206;435;1170;18096;4313;1152;3.58;41.6;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
33;23010;Journal of Controlled Release;journal;18734995, 01683659;1.38;Q1;282;235;701;7124;2537;691;3.55;30.31;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
34;22477;Investigational New Drugs;journal;01676997, 15730646;1.353;Q1;90;52;116;1555;441;114;3.22;29.9;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;1.347;Q1;331;116;362;8443;1690;327;4.43;72.78;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
36;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.347;Q1;169;93;224;7889;1227;216;5.11;84.83;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
37;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.344;Q1;117;16;61;2773;275;61;3.83;173.31;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
38;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.285;Q1;115;58;157;3246;440;156;3.62;55.97;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
39;26380;Drug and Alcohol Dependence;journal;03768716;1.265;Q1;173;129;371;5080;1072;360;2.72;39.38;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
40;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.26;Q1;163;195;529;8595;1984;525;3.88;44.08;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
41;23916;Environmental Pollution;journal;02697491, 18736424;1.254;Q1;249;307;624;10193;1360;603;2.1;33.2;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
42;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.245;Q1;129;110;344;4600;767;332;1.99;41.82;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
43;23053;Journal of Natural Products;journal;01633864, 15206025;1.238;Q1;147;431;1270;9054;2547;1267;2.06;21.01;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
44;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.207;Q1;175;196;676;8834;2237;664;3.14;45.07;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
45;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;1.187;Q1;85;342;726;13512;1552;724;2.12;39.51;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q1); Inorganic Chemistry (Q1); Organic Chemistry (Q1); Physical and Theoretical Chemistry (Q1); Biochemistry (Q2); Catalysis (Q2)"
46;20664;Current Drug Targets;journal;18735592, 13894501;1.182;Q1;107;40;50;4034;145;46;2.9;100.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
47;86329;Mutation Research - Mutation Research Genomics;journal;13835726, 18731341;1.178;Q1;20;0;28;0;76;28;2.79;0;Netherlands;Western Europe;Elsevier BV;1997-2001;"Toxicology (Q1); Genetics (Q2)"
48;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.175;Q1;36;11;21;1722;70;13;2.93;156.55;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
49;26795;Controlled Clinical Trials;journal;01972456;1.174;Q1;74;69;193;1634;373;165;1.85;23.68;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
50;25218;Toxicological Sciences;journal;10960929, 10966080;1.163;Q1;193;257;757;10012;2419;737;3.16;38.96;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
51;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.148;Q1;182;227;707;7033;2473;701;3.57;30.98;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
52;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.137;Q1;115;127;413;4698;826;411;1.8;36.99;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
53;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.135;Q1;168;89;226;2313;511;224;2.48;25.99;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
54;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.127;Q1;166;198;303;19253;1078;259;3.3;97.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
55;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.09;Q1;177;172;410;5814;1448;407;3.32;33.8;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
56;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.07;Q1;121;63;206;2077;530;179;2.72;32.97;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
57;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;1.064;Q1;93;149;496;5220;1297;493;2.55;35.03;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
58;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.06;Q1;159;277;905;11282;2259;887;2.43;40.73;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
59;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.06;Q1;100;34;88;3599;326;87;2.88;105.85;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
60;12611;Drug Resistance Updates;journal;13687646, 15322084;1.06;Q1;119;24;141;2029;378;134;2.54;84.54;United States;Northern America;Churchill Livingstone;1998-2021;"Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2)"
61;21167;Pharmacogenomics;journal;14622416, 17448042;1.058;Q1;94;84;75;4272;291;70;3.88;50.86;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
62;68602;Immunopharmacology;journal;01623109;1.044;Q1;68;0;281;0;825;275;4.3;0;Netherlands;Western Europe;Elsevier BV;1978-2000;Pharmacology (Q1)
63;20663;Current Drug Metabolism;journal;18755453, 13892002;1.041;Q1;111;39;48;5619;143;45;2.98;144.08;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
64;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.038;Q1;140;175;508;4826;1640;410;3.24;27.58;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
65;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.032;Q1;70;39;160;1714;397;154;2.61;43.95;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
66;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.028;Q1;76;75;171;4619;402;168;2.9;61.59;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Cell Biology (Q2); Physiology (Q2)"
67;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.018;Q1;78;100;358;1713;544;326;1.43;17.13;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
68;21841;Food Additives and Contaminants;journal;0265203X, 14645122;1.013;Q1;102;157;312;4049;575;308;1.68;25.79;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
69;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.012;Q1;213;263;794;7230;2181;780;2.39;27.49;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
70;21237;Drug Safety;journal;01145916, 11791942;1.006;Q1;131;96;253;5584;1067;245;4.09;58.17;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
71;21790;Antiviral Therapy;journal;20402058, 13596535;0.997;Q1;89;42;135;1113;332;121;3.18;26.5;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
72;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;0.976;Q1;76;15;42;2544;155;41;2.47;169.6;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
73;20026;BMC Clinical Pharmacology;journal;14726904;0.969;Q1;39;8;4;240;10;4;2.5;30;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
74;14805;Steroids;journal;0039128X, 18785867;0.962;Q1;107;134;326;4532;907;325;2.73;33.82;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q1); Endocrinology (Q1); Pharmacology (Q1); Biochemistry (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
75;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.96;Q1;186;262;575;7836;1491;571;2.22;29.91;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
76;21333;European Journal of Pharmacology;journal;00142999, 18790712;0.957;Q1;189;735;2679;28235;6863;2673;2.51;38.41;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
77;110112;Journal of Immunotherapy;journal;15249557, 15374513;0.953;Q1;97;36;134;1164;369;119;2.56;32.33;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2)"
78;19700180810;Alkaloids: Chemical and Biological Perspectives;book series;07358210;0.941;Q1;14;0;17;0;21;4;0;0;Netherlands;Western Europe;Elsevier;1996, 1998-1999, 2001;"Drug Discovery (Q1); Organic Chemistry (Q2)"
79;16117;Pharmaceutical Biotechnology;journal;10780467;0.918;Q1;27;16;17;1346;62;17;0;84.13;United States;Northern America;Kluwer/Plenum Publishers;1993, 1995-1999, 2002;"Applied Microbiology and Biotechnology (Q1); Pharmaceutical Science (Q1)"
80;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;0.916;Q1;95;54;176;2286;304;175;1.53;42.33;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
81;21744;Planta Medica;journal;14390221, 00320943;0.91;Q1;122;298;680;4896;1229;659;1.68;16.43;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2)"
82;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.9;Q1;66;66;110;2435;354;98;1.81;36.89;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
83;37409;Anti-Cancer Drug Design;journal;02669536;0.888;Q1;53;0;134;0;397;131;2.25;0;United States;Northern America;Cognizant Communication Corporation;1985-2001;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Drug Discovery (Q1); Oncology (Q1); Pharmacology (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
84;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.884;Q1;171;446;949;14440;2095;948;2.09;32.38;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
85;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;0.881;Q1;96;49;180;1414;344;180;1.89;28.86;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
86;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.877;Q1;154;811;2055;17160;4431;2054;2.2;21.16;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
87;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.859;Q1;83;70;219;2944;404;208;1.8;42.06;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
88;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;0.85;Q1;118;87;255;3509;580;234;2.2;40.33;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Biological Psychiatry (Q3)"
89;15840;Journal of Antibiotics;journal;00218820, 18811469;0.85;Q1;84;144;512;2185;717;419;1.38;15.17;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
90;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.846;Q1;114;142;503;4357;1229;499;2.35;30.68;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
91;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.845;Q1;104;68;174;3014;571;174;3.22;44.32;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
92;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;0.842;Q1;139;348;863;16305;1740;859;1.91;46.85;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q3)"
93;36497;Pharmaceutica Acta Helvetiae;journal;00316865;0.84;Q1;40;0;72;0;180;70;3;0;Netherlands;Western Europe;Elsevier BV;1945-2000;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
94;20634;Journal of Texture Studies;journal;00224901, 17454603;0.817;Q1;57;36;102;872;116;102;1.05;24.22;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q1); Pharmaceutical Science (Q1)"
95;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;0.815;Q1;229;461;1154;10274;2190;1140;1.76;22.29;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
96;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.809;Q1;90;46;147;1676;229;147;1.53;36.43;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Pharmacology (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2)"
97;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0.808;Q1;153;199;615;5276;1611;558;2.49;26.51;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
98;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.807;Q1;205;216;651;5942;1056;647;1.44;27.51;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
99;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;0.794;Q1;113;47;137;2392;299;131;2.42;50.89;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
100;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.791;Q1;144;115;352;3069;846;335;2.62;26.69;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
101;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;0.79;Q1;109;134;790;12336;1905;769;2.56;92.06;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
102;21165;PharmacoEconomics;journal;11707690, 11792027;0.787;Q1;104;107;355;4100;864;343;2.16;38.32;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
103;20680;Current Opinion in Molecular Therapeutics;journal;14648431;0.783;Q1;66;80;265;3419;606;246;2.58;42.74;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Pharmacology (Q1); Drug Discovery (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Genetics (Q3); Molecular Biology (Q3)"
104;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.781;Q1;103;106;294;3816;638;267;2;36;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
105;25219;Toxicology;journal;0300483X, 18793185;0.779;Q1;165;321;608;11282;1481;592;2.56;35.15;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
106;25075;Ecotoxicology;journal;09639292, 15733017;0.776;Q1;97;47;111;1629;173;106;1.51;34.66;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
107;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.776;Q1;104;234;921;7912;1819;913;1.79;33.81;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
108;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.771;Q1;79;56;137;1170;301;120;1.87;20.89;United States;Northern America;SAGE Publications Inc.;1996-2017;"Pharmacology (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q2)"
109;19617;Antiviral Research;journal;01663542, 18729096;0.766;Q1;134;92;208;3858;549;208;2.7;41.93;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
110;24763;Addictive Behaviors;journal;03064603;0.764;Q1;135;74;268;2584;406;266;1.37;34.92;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Psychiatry and Mental Health (Q2)"
111;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;0.752;Q1;139;107;92;5111;250;89;2.72;47.77;Netherlands;Western Europe;Elsevier BV;2001-2021;"Pharmacology (Q1); Drug Discovery (Q2)"
112;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.745;Q2;66;67;138;2978;327;127;2.1;44.45;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Medicine (miscellaneous) (Q1); Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
113;23412;Journal of AOAC International;journal;10603271;0.737;Q1;90;198;637;3958;777;635;1.07;19.99;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q1); Food Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2)"
114;25864;Heterocycles;journal;03855414;0.736;Q2;66;330;1140;8743;1299;1130;1.21;26.49;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
115;23009;Journal of Clinical Research;journal;13695207;0.733;Q2;11;2;30;22;14;30;0.63;11;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
116;25240;Toxicology Letters;journal;03784274, 18793169;0.728;Q1;150;274;597;8445;1315;592;2.37;30.82;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
117;24785;Alcohol;journal;07418329;0.726;Q1;83;75;271;2859;459;264;1.74;38.12;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Biochemistry (Q2); Neurology (Q2); Behavioral Neuroscience (Q3)"
118;29682;Receptors and Channels;journal;10606823;0.726;Q2;42;31;61;2887;82;59;1.03;93.13;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q2); Endocrinology (Q2); Pharmacology (Q2); Cell Biology (Q3)"
119;20473;Life Sciences;journal;18790631, 00243205;0.724;Q1;174;547;1856;18388;3920;1851;1.94;33.62;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
120;55157;Perspectives in Drug Discovery and Design;journal;15739023, 09282866;0.72;Q2;38;0;59;0;151;55;3.45;0;Netherlands;Western Europe;Kluwer Academic Publishers;1993-2000;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
121;18073;NeuroToxicology;journal;18729711, 0161813X;0.719;Q2;122;78;271;3787;567;270;1.64;48.55;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
122;16533;Phytochemical Analysis;journal;09580344, 10991565;0.719;Q2;76;58;173;1185;224;173;1.42;20.43;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
123;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.709;Q2;96;139;379;4781;816;377;2.21;34.4;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
124;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.708;Q1;133;521;940;12118;1532;936;1.5;23.26;Netherlands;Western Europe;Elsevier;1983-2022;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
125;18966;Mutagenesis;journal;02678357, 14643804;0.706;Q2;95;79;246;3210;475;242;1.86;40.63;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
126;22319;Toxicon;journal;18793150, 00410101;0.703;Q2;133;199;523;7101;1023;509;1.98;35.68;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
127;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.699;Q2;64;86;224;2550;333;212;1;29.65;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
128;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;0.697;Q2;195;145;1172;4208;2284;1117;2.18;29.02;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
129;4000150314;Chemical Biology and Drug Design;journal;17470277;0.691;-;82;71;355;2386;615;345;1.71;33.61;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
130;22432;International Immunopharmacology;journal;18781705, 15675769;0.69;Q2;119;175;199;7362;381;196;1.91;42.07;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
131;25109;Inhalation Toxicology;journal;08958378, 10917691;0.682;Q2;90;73;315;2827;425;304;1.33;38.73;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
132;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.68;Q2;95;347;1115;6864;1359;1115;1.23;19.78;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Medicine (miscellaneous) (Q1); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2)"
133;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.675;Q2;107;193;597;6677;1034;596;1.54;34.6;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
134;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.675;Q1;81;71;199;1274;239;197;1.07;17.94;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
135;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;0.664;Q2;134;193;295;7331;504;291;1.65;37.98;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q2); Biological Psychiatry (Q3)"
136;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.656;Q2;121;159;496;5124;1106;483;2.07;32.23;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
137;25898;Journal of Peptide Science;journal;10752617, 10991387;0.651;Q2;68;68;185;2111;304;180;1.64;31.04;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
138;25093;Environmental Toxicology;journal;15227278, 15204081;0.642;Q2;81;69;208;2114;265;203;0.96;30.64;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
139;14822;Xenobiotica;journal;00498254, 13665928;0.641;Q2;82;87;244;2880;558;242;2.09;33.1;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
140;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.635;Q2;80;61;189;2009;379;182;1.87;32.93;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
141;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.635;Q1;88;26;52;3513;97;49;1.87;135.12;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
142;24604;Archives of Toxicology;journal;14320738, 03405761;0.634;Q2;121;109;286;4198;577;284;2;38.51;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
143;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.622;Q2;114;127;473;2970;1006;444;1.9;23.39;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
144;23942;Biomedical Chromatography;journal;10990801, 02693879;0.618;Q2;68;83;300;1800;410;298;1.44;21.69;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
145;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.618;Q2;63;65;182;2258;312;161;1.54;34.74;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
146;110172;Progress in Drug Research;book series;0071786X;0.618;Q1;44;14;45;1733;99;40;2;123.79;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
147;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.617;Q2;92;128;398;5227;631;396;1.37;40.84;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
148;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.614;Q1;95;75;134;2687;280;128;2.12;35.83;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
149;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.612;Q2;62;40;129;1613;238;128;1.8;40.33;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
150;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.609;Q2;183;181;412;8645;843;401;1.8;47.76;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
151;16948;Chirality;journal;1520636X, 08990042;0.608;Q2;80;120;361;3570;603;356;1.68;29.75;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
152;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.605;Q1;36;10;71;302;141;70;2.5;30.2;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
153;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.603;Q2;112;78;224;4404;414;213;1.78;56.46;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
154;22410;Inflammation Research;journal;1420908X, 10233830;0.597;Q2;94;145;469;3756;724;459;1.56;25.9;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
155;21196;Drug Discovery Today;journal;18785832, 13596446;0.594;Q2;185;306;631;5798;1138;518;1.74;18.95;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
156;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.592;Q2;66;34;105;1323;137;102;1.06;38.91;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Biochemistry (Q3); Molecular Biology (Q3); Organic Chemistry (Q3)"
157;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.592;Q1;40;40;162;766;99;108;0.63;19.15;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q1)
158;61687;Antiviral Chemistry and Chemotherapy, Supplement;journal;13502816;0.586;Q2;11;0;17;0;32;17;1.88;0;Switzerland;Western Europe;World Health Organization;1993-1995, 1997, 2001;"Pharmacology (Q2); Virology (Q2)"
159;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.58;Q2;175;90;302;2733;496;298;1.7;30.37;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
160;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.58;Q2;64;56;177;1385;227;177;1.24;24.73;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
161;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.576;Q2;103;89;221;4413;430;220;1.65;49.58;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Developmental Neuroscience (Q3); Cellular and Molecular Neuroscience (Q4)"
162;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;0.575;Q2;91;92;84;7032;195;82;2.32;76.43;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2)"
163;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.575;Q2;81;71;219;2603;405;218;1.47;36.66;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3)"
164;16067;Reading Teacher;journal;00340561;0.568;Q2;53;87;188;1502;82;188;0.33;17.26;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
165;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.566;Q2;87;160;389;5893;557;388;1.45;36.83;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
166;24028;Reproductive Toxicology;journal;08906238, 18731708;0.56;Q2;117;60;198;2375;359;175;1.78;39.58;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
167;17067;Phytomedicine;journal;09447113, 1618095X;0.558;Q1;127;119;216;2988;352;212;1.65;25.11;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
168;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;0.547;Q2;90;63;56;2185;103;51;1.84;34.68;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
169;25214;Toxicologic Pathology;journal;15331601, 01926233;0.543;Q2;112;102;334;3450;509;316;1.33;33.82;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q4)"
170;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.541;Q2;96;118;344;3840;801;331;2.21;32.54;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
171;20677;Current Opinion in Drug Discovery and Development;journal;13676733;0.54;Q2;81;93;227;4784;394;213;1.97;51.44;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
172;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.537;Q2;64;25;61;595;97;59;1.62;23.8;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
173;16573;Phytotherapy Research;journal;10991573, 0951418X;0.532;Q2;140;193;447;4281;549;447;1.1;22.18;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
174;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.53;Q1;62;44;203;1162;153;196;0.75;26.41;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
175;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.529;Q2;54;35;107;1389;224;107;1.95;39.69;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
176;25934;Cytokines, Cellular and Molecular Therapy;journal;14660830, 13684736;0.528;Q2;27;21;55;776;87;55;1.31;36.95;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2000, 2002;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
177;23055;Journal of Natural Toxins;journal;10588108;0.515;Q2;26;44;98;1141;125;98;1.02;25.93;United States;Northern America;Alaken Inc.;1996-2002;"Environmental Science (miscellaneous) (Q1); Toxicology (Q2)"
178;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.515;Q2;75;50;163;1271;296;161;1.92;25.42;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
179;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.506;Q2;69;102;256;1858;420;244;1.78;18.22;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
180;36479;International Journal of Immunopharmacology;journal;01920561;0.506;Q2;50;0;201;0;334;194;1.67;0;Netherlands;Western Europe;Elsevier BV;1979-2000;"Pharmacology (Q2); Immunology (Q3)"
181;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.502;Q2;100;39;18;5020;22;18;1.22;128.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q2); Cancer Research (Q3); Molecular Medicine (Q3)"
182;81781;Pharmaceutical Science and Technology Today;journal;14615347;0.499;Q1;54;0;182;0;256;164;1.2;0;Netherlands;Western Europe;Elsevier BV;1998-2000;Pharmaceutical Science (Q1)
183;21169;Pharmacological Research;journal;10436618, 10961186;0.499;Q2;147;158;477;5332;726;477;1.44;33.75;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
184;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.497;Q2;62;44;142;1842;232;138;0.52;41.86;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
185;29311;Current Cancer Drug Targets;journal;15680096, 18735576;0.495;Q2;96;20;16;3075;24;16;1.5;153.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
186;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.494;Q2;90;127;480;3235;458;477;0.75;25.47;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
187;33349;Japanese Journal of Pharmacology;journal;13473506, 00215198;0.484;Q2;62;185;554;5609;706;553;1.22;30.32;Japan;Asiatic Region;Japanese Pharmacological Society;1951-2002;Pharmacology (Q2)
188;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.484;Q1;51;215;696;5066;613;692;0.9;23.56;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q1); Clinical Biochemistry (Q2); Analytical Chemistry (Q3); Biochemistry (Q3)"
189;24652;Chemico-Biological Interactions;journal;00092797;0.483;Q2;128;68;529;3384;784;525;1.35;49.76;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
190;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.48;Q1;12;0;7;0;7;5;0;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Infectious Diseases (Q2); Pharmacology (medical) (Q2); Virology (Q3)"
191;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.48;Q2;71;75;218;2612;214;182;0.93;34.83;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
192;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;0.474;Q2;94;54;131;5107;108;131;1.04;94.57;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Drug Discovery (Q2); Pharmacology (Q2); Clinical Biochemistry (Q3); Molecular Medicine (Q3)"
193;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.473;Q2;64;37;113;1481;185;111;1.38;40.03;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
194;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.467;Q2;50;34;108;1033;71;108;0.51;30.38;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q3)"
195;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.452;Q2;98;82;284;2559;381;231;1;31.21;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
196;21194;Pharmacology;journal;00317012, 14230313;0.452;Q2;60;93;210;2827;314;203;1.67;30.4;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
197;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.448;Q2;88;62;114;2747;170;110;1.26;44.31;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
198;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.447;Q2;39;33;116;862;172;114;0.55;26.12;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
199;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.444;Q2;63;73;168;1976;278;142;1.9;27.07;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
200;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.441;Q2;47;33;142;1791;187;140;1.6;54.27;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
201;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.44;Q3;74;61;190;1995;273;184;1.2;32.7;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
202;27210;In Vivo;journal;17917549, 0258851X;0.439;Q2;64;86;284;3603;342;282;1.23;41.9;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
203;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.438;Q1;122;350;940;8647;1107;930;1.16;24.71;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
204;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.438;Q2;78;66;145;1566;209;142;1.34;23.73;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
205;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.436;Q2;76;65;185;1607;311;166;1.58;24.72;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
206;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.435;Q2;77;132;419;7336;516;416;1.3;55.58;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
207;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.434;Q2;52;0;0;0;0;0;0;0;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Toxicology (Q2); Developmental Biology (Q3); Health, Toxicology and Mutagenesis (Q3)"
208;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.427;Q2;109;189;338;4950;418;293;0.99;26.19;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
209;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.424;Q1;39;37;116;894;80;112;0.49;24.16;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2)"
210;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.423;Q2;83;160;273;11187;453;263;1.7;69.92;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
211;21192;Drug Development Research;journal;02724391, 10982299;0.419;Q3;62;99;324;6376;393;316;1.25;64.4;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
212;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.418;Q2;99;448;1354;5277;1025;690;0.72;11.78;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
213;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.415;Q3;48;111;691;2479;368;689;0.82;22.33;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Radiology, Nuclear Medicine and Imaging (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Spectroscopy (Q3)"
214;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.414;Q2;113;151;363;6492;471;358;1.16;42.99;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Physiology (Q3)"
215;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;0.414;Q3;122;82;40;8958;65;40;1.63;109.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
216;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.411;Q2;73;49;131;1391;147;122;1.14;28.39;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
217;13671;Biologicals;journal;10958320, 10451056;0.41;Q2;60;36;131;678;134;126;0.96;18.83;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
218;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.408;Q3;76;254;700;4254;552;698;0.67;16.75;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pollution (Q3); Toxicology (Q3)"
219;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.406;Q2;91;189;594;5473;591;591;0.92;28.96;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
220;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.403;Q2;17;4;38;311;78;38;2.09;77.75;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q2)
221;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.4;Q2;52;114;364;2801;406;341;0.77;24.57;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3)"
222;38865;Natural Toxins;journal;10569014;0.4;Q3;47;0;56;0;105;55;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";1992-1999;Toxicology (Q3)
223;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.398;Q3;91;57;300;1832;339;296;1.15;32.14;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q3)
224;24578;Mathematical Medicine and Biology;journal;14778599;0.394;Q2;46;15;58;399;38;58;0.63;26.6;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Modeling and Simulation (Q3); Neuroscience (miscellaneous) (Q3)"
225;20570;Chemotherapy;journal;00093157, 14219794;0.392;Q2;58;53;250;1145;338;241;1.26;21.6;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3)"
226;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;0.392;Q2;79;235;36;11722;21;33;0.58;49.88;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
227;24071;Metal-Based Drugs;journal;07930291, 16875486;0.392;Q2;38;12;142;379;124;141;0.91;31.58;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Pharmacology (Q2); Drug Discovery (Q3); Inorganic Chemistry (Q3); Toxicology (Q3)"
228;20770;Drug Delivery;journal;10717544, 15210464;0.39;Q2;72;33;92;727;95;92;1.2;22.03;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
229;22378;Vascular Pharmacology;journal;18793649, 15371891;0.388;Q2;100;89;258;4331;238;256;0.59;48.66;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Molecular Medicine (Q3); Physiology (Q3)"
230;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.384;Q2;58;34;70;1338;208;67;3.81;39.35;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
231;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.384;Q2;52;57;200;1614;143;200;0.65;28.32;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
232;80381;Tumor Targeting;journal;13518488;0.384;Q2;10;0;32;0;35;31;0;0;United Kingdom;Western Europe;Stockton Press;1998-1999;"Pharmacology (Q2); Cancer Research (Q3)"
233;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.378;Q2;52;41;111;1206;131;101;1.35;29.41;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
234;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.373;Q2;48;261;797;4596;387;796;0.45;17.61;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
235;18077;Fitoterapia;journal;0367326X, 18736971;0.37;Q2;110;146;517;2046;291;517;0.6;14.01;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
236;17700156431;Handbook of Analytical Separations;book series;15677192;0.37;Q2;12;0;55;0;29;47;0.53;0;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pathology and Forensic Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q4)"
237;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.367;Q2;79;62;122;1620;127;122;1.01;26.13;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
238;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.361;Q3;41;46;100;7039;59;55;0.59;153.02;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
239;19900192900;Molecular Informatics;journal;18681751, 18681743;0.356;Q3;70;33;87;1445;120;87;1.41;43.79;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q4)"
240;21265;Drugs of the Future;journal;03778282;0.355;Q2;45;87;269;4423;303;269;1.09;50.84;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;23039;Journal of Liposome Research;journal;08982104, 15322394;0.352;Q2;53;35;102;685;89;84;0.89;19.57;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
242;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.35;Q2;32;9;19;145;26;17;1.37;16.11;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
243;22072;Current Gene Therapy;journal;18755631, 15665232;0.35;Q3;75;34;24;4126;26;24;1.08;121.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q3); Molecular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4)"
244;21717;Die Pharmazie;journal;00317144;0.35;Q2;66;209;716;4443;594;713;0.84;21.26;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
245;4400151608;ChemMedChem;journal;18607187, 18607179;0.346;Q2;106;139;399;3333;365;396;0.83;23.98;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3); Molecular Medicine (Q4)"
246;21186;Drug Design and Discovery;journal;10559612, 10292322;0.344;Q3;20;4;55;48;49;50;0.88;12;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q4)"
247;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.343;Q3;93;149;327;4026;294;327;0.87;27.02;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
248;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.343;Q3;93;117;323;4555;371;313;1.23;38.93;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Toxicology (Q3)"
249;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.342;Q2;50;35;102;976;93;100;0.78;27.89;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
250;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.341;Q2;31;16;45;391;67;45;0.89;24.44;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
251;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.34;Q3;77;57;183;1777;222;179;1.08;31.18;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
252;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.34;Q3;20;62;174;0;149;174;0.87;0;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
253;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.338;Q3;62;67;185;1715;159;182;0.72;25.6;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q2); Pharmacology (Q3)"
254;25106;Human and Experimental Toxicology;journal;09603271;0.337;Q3;82;114;324;2989;344;307;0.79;26.22;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
255;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.337;Q3;50;61;79;0;96;79;1.05;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
256;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.336;Q3;53;45;149;1659;159;149;0.78;36.87;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
257;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.335;Q3;46;35;118;982;108;118;1.01;28.06;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
258;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.331;Q3;98;225;645;4294;502;644;0.73;19.08;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
259;40278;Adverse Drug Reactions and Toxicological Reviews;journal;0964198X;0.33;Q3;24;19;61;1078;53;29;0.65;56.74;United Kingdom;Western Europe;Adis International Ltd;1991-2002;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
260;24097;Journal of the Indian Chemical Society;journal;00194522;0.33;Q3;33;268;524;5201;217;522;0.43;19.41;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q3); Electrochemistry (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
261;20051;BioDrugs;journal;11738804, 1179190X;0.329;Q3;71;47;230;3842;264;217;1.44;81.74;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Biotechnology (Q3); Pharmacology (Q3)"
262;21100470510;Drug Research;journal;21949379, 21949387;0.328;Q3;65;135;494;2948;468;488;0.87;21.84;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
263;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.328;Q3;95;51;38;4269;40;38;1.05;83.71;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
264;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.325;Q2;124;206;1182;6631;1017;1172;0.89;32.19;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
265;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.322;Q2;81;32;52;814;78;49;1.75;25.44;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
266;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.321;Q2;72;115;258;2868;106;257;0.31;24.94;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
267;20104;CNS Drug Reviews;journal;1080563X, 15273458;0.32;Q3;61;26;95;1806;91;95;1.47;69.46;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q3); Pharmacology (Q3)"
268;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.32;Q2;63;46;151;954;123;139;0.57;20.74;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
269;25224;Toxicology in Vitro;journal;18793177, 08872333;0.32;Q3;112;93;267;3010;359;265;1.59;32.37;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
270;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.319;Q2;65;65;212;1535;171;208;0.78;23.62;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q4)"
271;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.315;Q2;61;45;139;998;129;137;0.79;22.18;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
272;23489;Chemical Speciation and Bioavailability;journal;09542299;0.313;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
273;130089;Toxin Reviews;journal;15569543, 15569551;0.311;Q3;46;20;51;1741;54;47;0.78;87.05;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
274;24749;Addiction Biology;journal;13556215, 13691600;0.31;Q3;83;51;134;2045;96;131;0.82;40.1;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q2); Psychiatry and Mental Health (Q2); Pharmacology (Q3)"
275;25245;Veterinary and Human Toxicology;journal;01456296;0.307;Q3;41;117;304;1840;186;281;0.55;15.73;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Veterinary (miscellaneous) (Q3)"
276;22365;International Antiviral News;journal;09652310;0.295;Q3;8;0;75;0;36;52;0.73;0;United Kingdom;Western Europe;International Medical Press Ltd;1994-2001;"Pharmacology (Q3); Virology (Q3)"
277;16836;BMC Chemical Biology;journal;14726769;0.293;Q4;20;1;4;30;4;4;1;30;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q4); Molecular Medicine (Q4)"
278;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.291;Q2;50;69;231;745;74;224;0.34;10.8;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q4); Organic Chemistry (Q4)"
279;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.287;Q3;42;90;262;2373;223;222;0.83;26.37;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
280;21687;American Journal of PharmacoGenomics;journal;11752203;0.286;Q3;38;26;29;2101;30;29;1.03;80.81;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q3); Genetics (Q4); Molecular Medicine (Q4)"
281;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.284;Q3;55;30;27;2772;21;27;0.78;92.4;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q3); Molecular Medicine (Q4)"
282;25144;Journal of Health Science;journal;13475207, 13449702;0.284;Q3;49;93;278;2119;182;278;0.75;22.78;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
283;130063;Pharmacological Reports;journal;17341140;0.284;Q3;87;85;221;2760;190;221;0.78;32.47;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
284;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.281;Q3;21;35;0;1360;0;0;0;38.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
285;22375;Indian Drugs;journal;0019462X;0.279;Q2;31;137;433;1912;147;430;0.3;13.96;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
286;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.274;Q3;67;187;361;1772;313;338;0.9;9.48;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacy (Q1); Pharmacology (nursing) (Q2); Pharmacology (Q3)"
287;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.272;Q2;42;49;112;529;43;112;0.43;10.8;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3); Analytical Chemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
288;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.271;Q3;61;102;213;2359;268;175;1.15;23.13;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
289;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.27;Q3;51;25;68;2413;70;65;1.13;96.52;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
290;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.27;Q3;36;26;79;738;61;79;0.88;28.38;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
291;25171;Mycotoxin Research;journal;18671632, 01787888;0.269;Q3;40;60;145;623;50;144;0.3;10.38;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Microbiology (Q3); Toxicology (Q3)"
292;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.268;Q2;57;37;132;658;80;125;0.63;17.78;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
293;18071;Neurotoxicity Research;journal;14763524, 10298428;0.265;Q3;78;63;46;4607;28;46;0.6;73.13;United States;Northern America;Springer New York;1999, 2001-2021;"Neuroscience (miscellaneous) (Q3); Toxicology (Q3)"
294;52550;Pharmacology and Toxicology, Supplement;journal;09019936;0.262;Q3;7;0;11;0;6;10;0.6;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1990-2000;"Pharmacology (Q3); Toxicology (Q3)"
295;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.261;Q3;53;74;253;1563;88;202;0.38;21.12;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
296;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.256;Q2;45;83;286;1376;114;286;0.42;16.58;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
297;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.256;Q3;48;24;82;513;53;70;0.71;21.38;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4)"
298;75047;Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs;journal;14648474;0.254;Q3;5;0;35;0;10;30;0.29;0;United Kingdom;Western Europe;Current Drugs Ltd.;2000;"Pharmacology (Q3); Immunology (Q4)"
299;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.253;Q3;50;25;79;1343;58;79;0.8;53.72;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q3); Pharmacology (Q3)"
300;73430;Pharmaceutical Technology;journal;15432521;0.253;Q2;38;116;325;898;92;299;0.29;7.74;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
301;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.25;Q3;51;71;205;1679;45;195;0.21;23.65;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q2); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
302;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.247;Q3;52;37;105;557;46;101;0.3;15.05;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Statistics and Probability (Q4)"
303;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.246;Q3;70;49;218;1328;165;215;0.69;27.1;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
304;26370;Molecules;journal;14203049;0.244;Q2;171;102;573;2248;187;567;0.34;22.04;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Chemistry (miscellaneous) (Q3); Analytical Chemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
305;25253;Blutalkohol (discontinued);journal;00065250;0.242;Q3;13;21;96;333;43;95;0.6;15.86;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
306;79053;Natural Product Sciences;journal;12263907;0.242;Q4;28;39;106;758;32;106;0.26;19.44;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
307;54408;Pharmacy and Pharmacology Communications;journal;14608081;0.242;Q2;25;0;232;0;123;230;0.52;0;United Kingdom;Western Europe;Pharmaceutical Press;1993, 1995, 1998-2000;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
308;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.24;Q3;53;114;326;4155;214;326;0.58;36.45;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
309;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.237;Q3;39;40;241;1083;125;240;0.35;27.08;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Molecular Medicine (Q4)"
310;29053;Molecular Diversity;journal;1573501X, 13811991;0.232;Q4;58;0;27;0;5;26;0.19;0;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q2); Information Systems (Q3); Catalysis (Q4); Drug Discovery (Q4); Inorganic Chemistry (Q4); Molecular Biology (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
311;24659;Comments on Toxicology;journal;08865140;0.231;Q3;12;27;45;1001;17;33;0.6;37.07;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q3)
312;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.231;Q3;39;40;128;782;86;125;0.45;19.55;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
313;35190;Revista Espanola de Quimioterapia;journal;02143429;0.231;Q3;26;44;138;1655;69;121;0.58;37.61;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q3); Pharmacology (Q3)"
314;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.228;Q2;43;106;310;3357;136;310;0.49;31.67;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
315;20564;Ceska a Slovenska Farmacie;journal;12107816;0.222;Q2;17;56;165;1589;52;163;0.33;28.38;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q2)
316;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.221;Q3;29;33;31;761;11;29;0.35;23.06;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
317;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.22;Q2;10;47;124;294;29;122;0.17;6.26;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q2)
318;21867;Geneesmiddelenbulletin;journal;03044629;0.219;Q3;7;83;254;231;19;38;0.09;2.78;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
319;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.219;Q2;19;213;589;1159;71;577;0.11;5.44;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q2)
320;32946;Developments in Biological Standardization;journal;03015149;0.217;Q4;42;0;146;0;109;146;0.93;0;Switzerland;Western Europe;S. Karger AG;1974-2000;"Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Public Health, Environmental and Occupational Health (Q3); Drug Discovery (Q4)"
321;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.217;Q3;29;68;85;800;28;83;0.24;11.76;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
322;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.211;Q2;66;40;125;905;73;119;0.59;22.63;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q4)"
323;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.21;Q3;53;30;159;864;70;159;0.44;28.8;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
324;37381;In Vitro and Molecular Toxicology: Journal of Basic and Applied Research;journal;10979336;0.209;Q4;21;0;78;0;66;67;1.02;0;United States;Northern America;Mary Ann Liebert Inc.;1996-2001;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
325;21229;Drug News and Perspectives;journal;02140934;0.208;Q3;51;73;177;3964;90;177;0.43;54.3;Spain;Western Europe;Prous Science;1990-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
326;68818;International Journal of Geriatric Psychopharmacology;journal;13648233;0.208;Q3;11;0;29;0;12;28;0.44;0;United Kingdom;Western Europe;Stockton Press;1997-2000;"Geriatrics and Gerontology (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuropsychology and Physiological Psychology (Q4)"
327;21102;Pharmaceutical Journal;journal;00316873;0.208;Q2;28;2882;1642;1404;124;572;0.06;0.49;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
328;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.206;Q4;56;25;34;1156;12;34;0.35;46.24;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q3); Molecular Biology (Q4); Toxicology (Q4)"
329;21127;Pharmaceutical Technology Europe;journal;01646826;0.206;Q2;18;64;283;389;47;195;0.14;6.08;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q2)
330;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.206;Q2;46;38;110;724;37;109;0.25;19.05;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
331;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.204;Q3;6;26;71;472;15;66;0.22;18.15;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
332;91481;Pharmacology Reviews and Communications;journal;10288945;0.204;Q3;9;23;59;754;26;59;0.35;32.78;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2002;Pharmacology (Q3)
333;20578;Journal of Food and Drug Analysis;journal;10219498;0.203;Q3;63;41;111;1114;39;111;0.37;27.17;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
334;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.201;Q4;38;67;193;1533;59;190;0.24;22.88;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q4); Biochemistry (Q4); Bioengineering (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
335;4000148019;AAPS Journal;journal;15507416;0.2;Q3;118;89;173;2614;83;172;0.53;29.37;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q3)
336;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.199;Q3;69;68;201;1207;87;201;0.39;17.75;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Medicine (miscellaneous) (Q2); Education (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
337;15340;Developments in Biologicals;journal;14246074, 16622960;0.197;Q3;38;108;131;29;63;131;0.48;0.27;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
338;21496;Revista de Chimie (discontinued);journal;00347752;0.197;-;31;173;417;2581;93;417;0.23;14.92;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
339;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.195;Q3;20;29;103;487;34;92;0.32;16.79;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q2); Pharmaceutical Science (Q3)"
340;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.193;Q3;19;13;45;427;17;39;0.34;32.85;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
341;20027;BMC Pharmacology;journal;14712210;0.192;Q3;44;21;13;702;11;13;0.85;33.43;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
342;25197;Revista de Toxicologia (discontinued);journal;02127113;0.191;Q4;11;25;47;338;9;46;0.2;13.52;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
343;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.19;Q4;62;68;199;3368;75;182;0.42;49.53;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q4)
344;25189;Reviews in Toxicology;journal;13826980;0.19;Q4;20;0;13;0;6;13;0;0;Netherlands;Western Europe;IOS Press BV;1997-1999, 2001;Toxicology (Q4)
345;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.189;Q3;61;106;305;2113;68;304;0.21;19.93;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q3)
346;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.188;Q3;9;53;51;743;10;44;0.2;14.02;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q1); Pharmaceutical Science (Q3); Pharmacology (Q3)"
347;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.187;Q3;62;77;258;1462;61;181;0.26;18.99;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
348;34232;Toxicology Methods;journal;10517235;0.186;Q4;18;0;67;0;30;67;0.4;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2001;Toxicology (Q4)
349;130031;Journal of Toxicologic Pathology;journal;09149198;0.185;Q4;30;33;117;856;43;117;0.35;25.94;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
350;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.183;Q3;60;36;105;756;47;105;0.41;21;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
351;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.183;Q3;15;0;75;0;34;75;0.37;0;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q3); Physiology (Q4)"
352;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.181;Q3;19;48;59;619;9;51;0.15;12.9;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Medicine (miscellaneous) (Q2); Marketing (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
353;21716;Pharmazeutische Zeitung;journal;00317136;0.177;Q3;7;381;1588;1451;23;989;0.02;3.81;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
354;21264;Drugs in R and D;journal;11796901, 11745886;0.176;Q3;47;89;240;1238;68;240;0;13.91;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
355;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.173;Q3;53;74;326;4312;153;322;0.38;58.27;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
356;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.172;Q3;35;177;306;2303;84;302;0.46;13.01;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
357;52649;Pharmaceutical and Pharmacological Letters;journal;09399488;0.172;Q3;17;0;74;0;19;73;0.22;0;Germany;Western Europe;Stuttgart Medpharm Scientific Publishers;1996-2001;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
358;22881;Yaoxue Xuebao;journal;05134870;0.172;Q3;34;228;659;2772;105;659;0.18;12.16;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
359;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.168;Q3;7;31;80;873;31;80;0.47;28.16;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
360;79249;Modern Drug Discovery;journal;10998209;0.163;Q3;9;0;58;0;27;58;0.49;0;United States;Northern America;American Chemical Society;1998-2001;Pharmaceutical Science (Q3)
361;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.162;Q3;19;30;203;405;38;130;0.17;13.5;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
362;19407;Acta Poloniae Toxicologica;journal;12306967;0.16;Q4;4;18;75;560;6;75;0.08;31.11;Poland;Eastern Europe;Polskie Towarzystwo Toksykologiczne/Polish Society of Toxicology;1999-2002;Toxicology (Q4)
363;72755;Phytomedica;journal;09723293;0.16;Q3;4;17;42;247;8;41;0.14;14.53;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
364;19374;AAPS PharmSciTech;journal;15309932;0.159;Q3;101;39;76;801;36;72;0.47;20.54;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Agronomy and Crop Science (Q4); Aquatic Science (Q4); Drug Discovery (Q4); Ecology (Q4); Ecology, Evolution, Behavior and Systematics (Q4)"
365;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.159;Q3;7;5;18;302;2;18;0.17;60.4;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
366;66652;Toxic Substance Mechanisms;journal;10769188;0.159;Q4;12;0;31;0;15;29;0.33;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2000;"Pollution (Q4); Toxicology (Q4)"
367;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.158;Q4;48;6;206;1312;62;206;0.23;218.67;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
368;21077;Pharmaca;journal;00316857;0.157;Q3;5;9;28;288;13;28;0.44;32;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
369;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.156;Q4;37;23;113;565;21;109;0.17;24.57;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
370;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.155;Q3;47;33;28;582;4;28;0.14;17.64;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
371;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.154;Q3;20;26;98;451;12;98;0.14;17.35;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
372;23171;Korean Journal of Pharmacognosy;journal;02533073;0.152;Q3;17;65;140;1229;20;140;0.12;18.91;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
373;13718;Pharmaceutical Engineering;journal;02738139;0.152;Q3;16;50;122;250;20;121;0.1;5;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
374;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.152;Q3;19;12;21;100;8;21;0.38;8.33;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q3)"
375;23277;Acta Physiologica Pharmacologica et Therapeutica Latinoamericana;journal;03276309;0.151;Q3;13;0;38;0;13;37;0;0;Argentina;Latin America;Association Latinoamericana de Ciencias Fisiologicas;1991-1999;"Pharmacology (Q3); Physiology (Q4)"
376;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.151;Q4;39;16;117;360;20;117;0.19;22.5;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
377;19484;Antibiotics and chemotherapy;journal;00664758, 16622863;0.15;Q3;8;0;18;0;10;18;0.56;0;Switzerland;Western Europe;S. Karger AG;1956, 1964-1965, 1968-1971, 1974-1976, 1978-1983, 1985, 1987-1989, 1991-1992, 1994-1996, 1998, 2000;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
378;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.15;-;31;47;32;691;9;32;0.24;14.7;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
379;22411;Inflammopharmacology;journal;09254692, 15685608;0.149;Q3;55;33;89;1806;35;89;0.4;54.73;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
380;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.149;Q3;29;28;51;728;9;46;0.17;26;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
381;20065;BioPharm International;trade journal;1542166X, 19391862;0.147;Q3;29;110;359;1054;54;322;0.16;9.58;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
382;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.145;Q4;19;124;367;2663;84;333;0.17;21.48;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
383;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.143;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
384;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.143;Q4;24;83;212;1247;33;212;0.22;15.02;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
385;16893;Biogenic Amines;journal;15693910, 01688561;0.141;Q4;15;18;85;705;16;85;0.2;39.17;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
386;22338;Hospital Pharmacy;journal;19451253, 00185787;0.141;Q4;24;163;491;1733;75;406;0.17;10.63;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (medical) (Q3); Pharmacology (Q4)"
387;22514;Japanese Journal of Chemotherapy;journal;13407007;0.141;Q4;12;88;238;1464;49;238;0.11;16.64;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
388;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.139;Q3;14;29;121;1069;13;121;0.07;36.86;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
389;22977;Journal de Pharmacie de Belgique;journal;00472166;0.139;Q3;12;27;73;300;14;73;0.2;11.11;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
390;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.139;Q4;6;5;45;109;8;44;0.07;21.8;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q3); Pharmacology (Q4)"
391;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.139;Q3;9;37;82;749;5;69;0.05;20.24;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
392;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.137;Q4;7;10;56;231;11;56;0.19;23.1;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
393;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.136;Q4;12;83;270;1046;34;269;0.1;12.6;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
394;21142;Pharmaceutisch Weekblad;journal;00316911;0.136;Q4;9;416;1487;2843;86;1069;0.08;6.83;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
395;21758;Prescrire International;journal;11677422;0.136;Q4;13;116;269;1222;61;238;0.26;10.53;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
396;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.135;Q3;27;57;180;1140;42;165;0.14;20;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
397;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.135;Q4;24;64;153;1106;44;127;0.32;17.28;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
398;110097;Food and Drug Law Journal;journal;1064590X;0.135;Q4;22;34;114;0;34;113;0.3;0;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
399;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.133;Q3;13;80;134;1447;14;126;0.09;18.09;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
400;22934;Chinese Pharmaceutical Journal;journal;10012494;0.13;Q3;21;325;875;3645;62;874;0.07;11.22;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
401;22205;Saudi Pharmaceutical Journal;journal;13190164;0.129;Q3;57;27;79;1008;18;75;0.29;37.33;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
402;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.128;Q4;13;44;140;527;22;103;0.12;11.98;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
403;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.127;Q3;10;8;30;116;6;30;0.2;14.5;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Pharmaceutical Science (Q3); Cell Biology (Q4); Molecular Biology (Q4); Pharmacology (medical) (Q4)"
404;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.126;Q3;43;49;113;1950;13;108;0.15;39.8;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
405;62531;Pharmaceutical News;journal;1071894X;0.125;Q3;11;66;101;1467;13;87;0.13;22.23;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2002;Pharmaceutical Science (Q3)
406;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.124;Q4;7;52;310;466;6;310;0.02;8.96;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
407;19408;Actualites Pharmaceutiques;journal;05153700;0.123;Q4;5;106;215;255;3;202;0.02;2.41;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
408;21798;Farmaceutski Glasnik;journal;00148202;0.123;Q3;6;15;69;231;2;69;0.08;15.4;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
409;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.123;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
410;60295;Acta Technologiae et Legis Medicamenti;journal;11212098;0.121;Q3;5;0;10;0;1;10;0;0;Italy;Western Europe;Maccari Editore Srl;1995-1999;Pharmaceutical Science (Q3)
411;145693;Canadian Pharmacists Journal;journal;17151635;0.121;Q3;24;117;350;627;11;239;0.03;5.36;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
412;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.121;Q3;4;17;180;549;9;180;0.09;32.29;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
413;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.121;Q4;33;48;199;1518;18;199;0.07;31.63;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
414;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.121;Q4;46;23;0;679;0;0;0;29.52;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
415;26767;Altex;journal;1868596X, 18688551;0.12;Q4;57;36;70;0;18;64;0.26;0;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
416;66831;Proceedings of the Controlled Release Society;journal;10220178;0.12;Q3;14;0;596;0;39;596;0;0;United States;Northern America;Controlled Release Society, Inc.;1993-1999;Pharmaceutical Science (Q3)
417;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.12;Q3;32;209;453;1952;26;452;0.06;9.34;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4)"
418;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.119;Q4;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
419;22908;Chinese Pharmacological Bulletin;journal;10011978;0.119;Q4;17;251;652;2930;54;652;0.07;11.67;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
420;38938;Japanese Journal of Toxicology and Environmental Health;journal;0013273X;0.119;Q4;12;0;17;0;3;17;0;0;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-1961, 1963-1999;Toxicology (Q4)
421;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0.119;Q4;16;20;14;930;10;10;0.71;46.5;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology (Q4)
422;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.118;Q4;21;8;31;377;4;12;0.1;47.13;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
423;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.117;Q4;17;24;58;1098;3;55;0.03;45.75;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
424;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.116;Q4;42;11;8;951;2;8;0.25;86.45;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Cardiology and Cardiovascular Medicine (Q4); Hematology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
425;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.116;Q3;46;177;766;2467;217;752;0.26;13.94;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4); Public Health, Environmental and Occupational Health (Q4)"
426;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.115;Q4;3;13;48;205;3;44;0.1;15.77;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
427;20543;Pharmacometrics;journal;03008533;0.114;Q4;6;19;40;303;4;40;0.04;15.95;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
428;20572;PZ Prisma;journal;09455566;0.114;Q4;5;34;99;550;8;85;0.06;16.18;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
429;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.113;Q4;34;190;537;2567;15;535;0.02;13.51;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
430;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.112;Q4;8;0;49;0;4;47;0.08;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
431;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.111;Q4;9;0;42;0;5;42;0.12;0;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
432;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.111;Q4;32;24;140;971;11;122;0.15;40.46;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
433;19700175108;Drug Delivery System;journal;18812732, 09135006;0.111;Q4;8;27;112;639;10;112;0.03;23.67;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
434;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.111;Q4;9;30;37;335;1;36;0;11.17;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
435;15842;Journal of Applied Research;journal;1537064X;0.11;Q4;22;21;18;543;2;18;0.11;25.86;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
436;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.11;Q4;87;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
437;21826;Revista Brasileira de Farmacia;journal;0370372X;0.11;Q4;9;0;38;0;4;38;0.15;0;Brazil;Latin America;Associacao Brasileira De Farmaceuticos;1945, 1984-2000;Pharmaceutical Science (Q4)
438;59522;Current Therapeutics;journal;0311905X;0.109;Q4;5;163;258;1061;10;258;0.04;6.51;Australia;Pacific Region;ADIS Press;1974-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
439;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.109;Q4;2;0;6;0;1;5;0;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
440;22979;Journal of Applied Therapeutic Research;journal;10292659;0.108;Q4;8;0;28;0;3;28;0;0;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
441;58672;Prescribers' Journal;journal;00327611;0.108;Q4;6;0;73;0;7;56;0.03;0;United Kingdom;Western Europe;Her Majesty's Stationery Office;1970, 1973-2000;Pharmaceutical Science (Q4)
442;21813;Research Communications in Alcohol and Substances of Abuse;journal;10808388;0.108;Q4;5;0;16;0;2;16;0;0;United States;Northern America;PJD Publications Ltd;1994-1999, 2001;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
443;25196;Revista Brasileira de Toxicologia;journal;14152983;0.107;Q4;7;16;27;486;3;24;0.11;30.38;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
444;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.107;Q4;14;22;66;287;5;66;0;13.05;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
445;54564;Antimicrobics and Infectious Diseases Newsletter;journal;1069417X;0.106;Q4;5;6;18;114;1;18;0.06;19;Netherlands;Western Europe;Elsevier BV;1994-1998, 2000, 2002;"Microbiology (medical) (Q4); Pharmacology (Q4)"
446;69108;Chemotherapie Journal, Supplement;journal;09446486;0.106;Q4;6;6;45;98;7;44;0.21;16.33;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
447;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.106;Q4;13;42;152;695;9;93;0.04;16.55;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
448;21837;Revista Portuguesa de Farmacia;journal;0484811X;0.106;Q4;5;0;60;0;7;60;0.05;0;Portugal;Western Europe;Ordem dos Farmaceuticos;1961, 1990-2001;Pharmaceutical Science (Q4)
449;79257;Antiinfective Drugs and Chemotherapy;journal;09464832;0.105;Q4;6;0;4;0;1;4;0.25;0;Germany;Western Europe;Futuramed Publishers Gmbh;1994-1998, 2000;Pharmacology (Q4)
450;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.105;Q4;20;0;73;0;7;73;0.06;0;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
451;19700180737;Pharmacochemistry Library;journal;01657208;0.105;Q4;10;25;23;871;3;21;0.13;34.84;Netherlands;Western Europe;Elsevier;1995-1998, 2000, 2002;"Drug Discovery (Q4); Organic Chemistry (Q4); Pharmacology (Q4)"
452;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.105;Q4;14;26;51;217;3;51;0.09;8.35;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
453;5800207507;Side Effects of Drugs Annual;book series;03786080;0.105;Q4;6;52;153;3813;9;153;0.07;73.33;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
454;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.104;Q4;2;1;5;86;1;5;0.33;86;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
455;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.104;Q4;15;130;448;2085;21;448;0.04;16.04;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
456;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.104;Q4;18;0;77;0;5;76;0.08;0;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
457;21238;Drug Topics;journal;19378157, 00126616;0.103;Q4;8;226;1366;0;40;960;0.03;0;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
458;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.103;Q4;5;0;50;0;1;50;0;0;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
459;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.103;Q4;35;90;119;1433;3;106;0;15.92;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
460;63556;Pharmacie Hospitaliere Francaise;journal;03699579;0.103;Q4;4;0;98;0;6;97;0;0;France;Western Europe;Syndicat des Pharmaciens Gerants;1982-2000;Pharmaceutical Science (Q4)
461;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.102;Q4;6;35;119;0;6;119;0.05;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
462;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.102;Q4;11;0;34;0;4;34;0.04;0;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
463;21329;European Journal of Herbal Medicine;journal;13524755;0.102;Q4;2;6;14;68;1;9;0.07;11.33;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology (Q4)
464;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.102;Q4;9;10;8;0;0;8;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
465;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.102;Q4;16;130;585;1992;24;584;0.05;15.32;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
466;88338;Journal of Pharmacoepidemiology;journal;08966966;0.102;Q4;4;0;11;0;0;9;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";1991, 1994-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
467;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.101;Q4;11;7;36;126;2;26;0.06;18;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
468;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.101;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
469;18800156720;Dissolution Technologies;journal;1521298X;0.101;Q4;34;14;44;59;7;19;0.19;4.21;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q4)
470;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.101;Q4;5;20;27;642;0;27;0;32.1;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
471;37682;Gyogyszereszet;journal;00176036;0.101;Q4;2;0;26;0;0;26;0;0;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1960-1962, 1973-1985, 1988-2000;Pharmacology (Q4)
472;22457;International Pharmacy Journal;journal;10100423;0.101;Q4;4;0;70;0;1;65;0;0;Netherlands;Western Europe;International Pharamaceutical Federation/Federation Internationale Pharmaceutique;1987-1999;Pharmaceutical Science (Q4)
473;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;0;25;0;0;24;0;0;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
474;94039;Journal of Managed Pharmaceutical Care;journal;15349721, 15349713;0.101;Q4;3;0;35;0;0;34;0;0;United States;Northern America;Pharmaceutical Products Press;2001;"Leadership and Management (Q4); Pharmacology (Q4)"
475;97159;Journal of Research in Pharmaceutical Economics;journal;08966621;0.101;Q4;5;0;36;0;0;29;0;0;United States;Northern America;Pharmaceutical Products Press;1996-1998, 2000-2001;"Health Policy (Q4); Pharmaceutical Science (Q4)"
476;23169;Klinische Pharmakologie Aktuell;journal;09395164;0.101;Q4;3;0;27;0;0;15;0;0;Germany;Western Europe;W.Zuckschwerdt Verlag GmbH;1995-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
477;21823;Pharmacia;journal;04280296;0.101;Q4;16;10;49;143;0;47;0;14.3;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
478;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.101;Q4;9;15;30;172;1;30;0.11;11.47;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
479;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.101;Q4;18;21;30;652;0;30;0;31.05;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
480;74999;American Druggist;journal;01905279;0.1;Q4;3;0;48;0;0;45;0;0;United States;Northern America;Hearst Corp;1946-1949, 1983-1999;Pharmaceutical Science (Q4)
481;22887;Chinese Journal of Antibiotics;journal;10018689;0.1;Q4;11;89;479;781;5;436;0.01;8.78;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
482;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;23;131;236;0;115;0;10.26;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
483;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.1;Q4;34;12;59;0;0;59;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
484;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.1;Q4;28;22;90;0;0;90;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
485;72763;Drugs Made in Germany;journal;00126683;0.1;Q4;4;13;40;169;0;37;0;13;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1964, 1973-2002;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
486;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.1;Q4;8;17;38;319;2;38;0.08;18.76;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
487;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;43;52;482;0;52;0;11.21;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
488;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.1;Q4;6;11;36;237;0;36;0;21.55;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
489;13637;Manufacturing Chemist;trade journal;02624230;0.1;Q4;6;0;1590;0;3;118;0;0;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
490;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.1;Q4;5;11;57;188;0;57;0;17.09;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
491;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.1;Q4;10;13;43;326;0;42;0;25.08;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
492;63560;Pharmaceutical Visions;journal;09661719;0.1;Q4;1;0;125;0;2;67;0.03;0;United Kingdom;Western Europe;London Monarch Communications;1997-2001;Pharmaceutical Science (Q4)
493;21227;Pharmacy in Practice;journal;13581538;0.1;Q4;5;21;64;222;0;46;0;10.57;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
494;17716;Quality Assurance Journal;journal;10991786, 10878378;0.1;Q4;9;29;60;72;1;51;0.02;2.48;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
495;9500153934;Therapiewoche;journal;02566869;0.1;Q4;1;32;62;21;1;52;0.02;0.66;Austria;Western Europe;Therapiewoche Verlag;2000-2002;Pharmacology (Q4)
496;36238;Therapiewoche Schweiz;journal;02566869;0.1;Q4;1;0;46;0;0;44;0;0;Switzerland;Western Europe;Therapiewoche Verlag;1990-2000;Pharmacology (Q4)
497;18005;American Journal of Respiratory Medicine;journal;11756365;;-;32;51;0;3419;0;0;0;67.04;United Kingdom;Western Europe;Adis International Ltd;2002-2003;"Pharmacology; Pulmonary and Respiratory Medicine"
498;19446;American Pharmaceutical Review;journal;10998012;;-;24;71;0;792;0;0;0;11.15;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science
499;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;;-;58;12;0;87;0;0;0;7.25;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery; Molecular Medicine"
500;28792;Cancer Biology and Therapy;journal;15384047, 15558576;;-;120;136;0;4683;0;0;0;34.43;United States;Northern America;Landes Bioscience;2002-2021;"Cancer Research; Molecular Medicine; Oncology; Pharmacology"
501;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;;-;90;43;0;5827;0;0;0;135.51;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous); Neuroscience (miscellaneous); Pharmacology"
502;20661;Current Drug Discovery;journal;14727463;;-;12;174;0;0;0;0;0;0;United Kingdom;Western Europe;Current Drugs Ltd.;2002-2004;Pharmacology
503;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;;-;51;26;0;3033;0;0;0;116.65;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Immunology; Immunology and Allergy; Pharmacology"
504;94084;Drug Discovery Today: TARGETS;journal;17418372;;-;15;45;0;823;0;0;0;18.29;Netherlands;Western Europe;Elsevier BV;2002-2004;Drug Discovery
505;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;;-;69;65;0;2178;0;0;0;33.51;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
506;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;10;40;181;30;40;0.85;18.1;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
507;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;;-;3;95;0;213;0;0;0;2.24;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science
508;20783;Expert Review of Vaccines;journal;14760584, 17448395;;-;91;57;0;3050;0;0;0;53.51;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery; Immunology; Molecular Medicine; Pharmacology"
509;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;;-;65;22;0;535;0;0;0;24.32;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Bioengineering; Biomedical Engineering; Biotechnology; Computer Science Applications; Electrical and Electronic Engineering; Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
510;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;12;0;157;0;0;0;13.08;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
511;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;;-;11;9;0;225;0;0;0;25;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
512;22906;Journal of China Pharmaceutical University;journal;10005048;;-;14;136;0;981;0;0;0;7.21;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science; Pharmacology"
513;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;;-;38;38;0;1193;0;0;0;31.39;United States;Northern America;Old City Publishing;1996, 2002-2020;"Cancer Research; Drug Discovery; Pharmacology"
514;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;16;72;189;4;71;0.06;11.81;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
515;21281;Journal of Immunotherapy;journal;10538550;;-;46;40;98;1608;266;98;2.64;40.2;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2004;"Cancer Research; Immunology; Pharmacology"
516;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;;-;22;33;0;949;0;0;0;28.76;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology
517;29634;Journal of Negative Results in BioMedicine;journal;14775751;;-;23;3;0;34;0;0;0;11.33;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
518;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;34;133;821;16;132;0.11;24.15;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
519;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;;-;348;232;0;7326;0;0;0;31.58;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery; Medicine (miscellaneous); Pharmacology"
520;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;28;112;781;20;108;0.21;27.89;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
521;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;;-;6;32;0;77;0;0;0;2.41;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy; Pharmaceutical Science"
522;21211;Pharmacy Education;journal;14772701, 15602214;;-;18;36;0;335;0;0;0;9.31;Netherlands;Western Europe;;1973-1978, 2002-2021;"Education; Pharmaceutical Science; Pharmacy"
523;34348;Teratogenesis Carcinogenesis and Mutagenesis;journal;02703211;;-;40;49;114;1484;157;110;1.36;30.29;United States;Northern America;"John Wiley &amp; Sons Inc.";1980-2003;"Genetics; Genetics (clinical); Health, Toxicology and Mutagenesis; Oncology; Toxicology"
524;38272;Teratology;journal;00403709;;-;73;109;298;3243;494;238;1.69;29.75;United States;Northern America;"John Wiley &amp; Sons Inc.";1968-2002;"Developmental Biology; Embryology; Health, Toxicology and Mutagenesis; Toxicology"
